Danaher Corp

Research Danaher Corp (DHR) on Bullrun: valuation model: 5.3% overvalued, market cap USD 136.44B, P/E 37.3, dividend yield 0.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerDHR
ExchangeNYSE
CountryUnited States
SectorHealthcare
IndustryDiagnostics & Research
CurrencyUSD
Valuation signal5.3% overvalued
Market capUSD 136.44B
P/E37.3
Dividend yield0.7%
Financial periodFY2025
RevenueUSD 24.57B
Revenue growth2.9%
Net incomeUSD 3.61B
Free cash flowUSD 5.26B
Gross margin59.1%

Valuation Snapshot

Bullrun's latest valuation model marks Danaher Corp as 5.3% overvalued; latest market cap is USD 136.44B; P/E is 37.3; dividend yield is 0.7%.

About Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services;

Frequently asked questions

Is Danaher Corp overvalued or undervalued?

Bullrun's valuation model currently marks Danaher Corp as 5.3% overvalued.

What is Danaher Corp's market cap?

Danaher Corp's market capitalization is USD 136.44B.

What is Danaher Corp's P/E ratio?

Danaher Corp's price-to-earnings (P/E) ratio is 37.3.

Does Danaher Corp pay a dividend?

Danaher Corp has a dividend yield of 0.7%.